MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities
$238,000K
Cash and cash
equivalents
$175,000K
Accounts receivable, net
$121,000K
Prepaid expenses and
other assets
$68,000K
Inventory
$55,000K
Total current assets
$657,000K
Property, plant, and
equipment, net
$239,000K
Intangible assets, net
$174,000K
Marketable securities
$121,000K
Other assets
$61,000K
Goodwill
$44,000K
Total assets
$1,296,000K
Accumulated deficit
-$4,717,000K
Treasury stock, at cost,
0.3 in 2026 and 0.2 in...
$10,000K
Total liabilities,
noncontrolling interest and...
$1,296,000K
Total stockholders'
equity (deficit)
-$236,000K
Additional paid-in capital
$4,481,000K
Deferred compensation
obligation
$10,000K
Total liabilities
$1,525,000K
Noncontrolling interest
$7,000K
Liabilities for sales of
future royalties
$1,128,000K
Total current
liabilities
$325,000K
Other liabilities
$42,000K
Deferred tax liabilities
$30,000K
Accrued liabilities
$194,000K
Liabilities for sales of
future royalties
$72,000K
Accounts payable
$42,000K
Other liabilities
$17,000K
Back
Back
Balance Sheet
source: myfinsight.com
Ultragenyx Pharmaceutical Inc. (RARE)
Ultragenyx Pharmaceutical Inc. (RARE)